Emmanuel Munyeshyaka

Mr. Emmanuel Munyeshyaka

Molecular Microbiology, Kagawa University, Miki, Japan
orcid
PhD, Kagawa University Faculty of Medicine, Department of Mo...

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2021 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
EMEmmanuel Munyeshyaka
Emmanuel Munyeshyaka
PCParfait Cyuzuzo
Parfait Cyuzuzo
CYCallixte Yadufashije
Callixte Yadufashije
JKJohn Karemera
John Karemera
Nosocomial infections or hospital-acquired infections are infections that potentially occur in the patients under medical care. These infections are often caused by multidrug-resistant pathogens acquired via improper antibiotic use, not following infection control and prevention procedures. The main objective of this study was to investigate the contribution of medical wards contamination to wound infection and antibiotics susceptibility patterns at Ruhengeri Referral Hospital, Musanze district, Rwanda. This was a cross-sectional study where a total of 61 samples including air sampling to evaluate the contamination by airborne bacteria, working surface, equipment, and patients’ surgical wounds swabs were collected in intensive care unit (ICU), pediatrics, and surgery departments. Culture, Gram stain, and biochemical tests were performed for microbiological isolation and identification. Antibiotic susceptibility testing was performed using the Kirby–Bauer disc diffusion method. Statistical Package for Social Science (SPSS) version 22 was used for data analysis. Gram-negative bacteria were frequently from surgery, pediatric, and ICU with 68.8%, 63.9%, and 31.1%, respectively, while Gram-positive isolates were 37.7% in surgery, 32.9% in pediatric, and 18.0% in ICU. There was a statistically significant association with E. coli and swabbed materials and surgical wound sites (x2 = 10.0253, value = 0.018). All bacterial contaminants were sensitive to clindamycin and erythromycin. Pseudomonas aeruginosa, E. coli, and S. aureus were resistant to nitrofurantoin. Hospital environment could be a contributing factor to surgical wound site infections. Hospitals should apply preventive measures in the hospital environment surrounding wound surgery patients to prevent wound infections during hospital stay.

29 February 2020 in Asian Journal of Medical Sciences
Verified
Journal Article
Open access
PDF file
CYCallixte Yadufashije
Callixte Yadufashije
ANAdolyne Niyonkuru
Adolyne Niyonkuru
EMEmmanuel Munyeshyaka
Emmanuel Munyeshyaka
SMSibomana Madjidi
Sibomana Madjidi
JMJoseph Mucumbitsi
Joseph Mucumbitsi
Background: Ginger (Zingiber officinale) has been used for long time due to its potential antimicrobial activity against diversity of microbial pathogens. Aims and Objectives: The study was carried out to investigate the bacteria pathogens found in digestive tract infections and assess antimicrobial activities of ginger extract to identified bacteria. Materials and Methods: Bacteriological studies were carried out on stool samples from 30 patients attending Muhoza health center. Different types of bacteria were isolated from stool samples of digestive tract infection patients by using various methods such culture, biochemical test and antimicrobial activity of ginger extracts was analyzed at INES-Ruhengeri in clinical microbiology laboratory. Results: Study findings showed isolated bacteria and antibacterial activity of Ginger. Isolated bacteria and their percentages including Escherichia coli (46.6%) which is the predominant isolated bacteria, Salmonella species (33.33%), Enterobacter spp (10.0%), Shigella spp (6.6%) and Citrobacter (3.33%) which is the least isolated bacteria. Antibacterial activity of ginger was seen on isolated bacteria, as ethanol and methanol were used for ginger oil extraction, the antibacterial activity of ginger extracts using ethanol was seen on isolated bacteria such us Citrobacter spp with 14 mm of inhibition zone, Shigella spp with 12 mm, Salmonella with 11.1 mm, E. coli with 9.5 mm and Enterobacter spp which was seen to be resistant to ginger extract using ethanol with 0.66mm of inhibition zone. For methanol extracts antibacterial activity was seen as follows: Citrobacter spp at 12 mm, Shigella spp at 11 mm, E. coli at 8 mm, salmonella spp at 6.1 mm, and Enterobacter spp with 5 mm. Enterobacter spp was seen to be the most resistant bacteria in both extracts. Conclusion: Ginger has shown to have an antibacterial activity on bacteria isolated from digestive tract infected patients. It can be used as a medicine to treat these infections. Number of researches should be done to be sure on this reality of antibacterial activity of ginger.

Verified
Journal Article
Open access
PDF file
NTNAFISA TABASSUM
NAFISA TABASSUM
NHNakayama-Imaohji Haruyuki
Nakayama-Imaohji Haruyuki
EMEmmanuel Munyeshyaka
Emmanuel Munyeshyaka
ATAyano Tada
Ayano Tada
TKTakeo Kondo
Takeo Kondo
TKTomomi Kuwahara
Tomomi Kuwahara
Ulcerative colitis (UC) is caused by an excessive immune response to gut microbiota. A recent study reported that the population of IgG-coated gut microbes increases with disease severity in patients with UC, but the role of these IgG-coated microbes in UC pathology is unclear. Serum, feces and colonoscopic lavage fluids (CLFs) were collected from pediatric UC (n = 13) and non-inflammatory bowel disease (IBD) patients (n = 15). Gut microbes were isolated from feces. Serum IgG reactivity to microbial cells and CLF-derived proteins was evaluated by Western blotting. Complement activation by the bacteria–IgG complexes was also assessed. Serum IgG reactivity to gut microbial extracts was highly variable in patients with active UC and increased with mucosal inflammation. IgG reactivity and clinical condition were inversely associated depending on disease activity. Non-IBD patients showed a similar degree of serum IgG response as that seen for patients whose UC was in remission. Lactobacillaceae bound higher amounts of IgG than other gut microbes tested and absorbed IgG to other bacteria. Lacticaseibacillus paracasei suppressed complement activation by Escherichia coli—IgG immune complexes. Appropriate IgG responses to luminal microbes might play a key role in gut microbiota stability by reducing excessive mucosal inflammation.

19 February 2025 in Beni-Suef University Journal of Basic and Applied Sciences
Verified
Journal Article
Open access
PDF file
Martin NDAYAMBAJEMartin NDAYAMBAJE
Martin NDAYAMBAJE
EMEmmanuel Munyeshyaka
Emmanuel Munyeshyaka
ODOlive Dieumerci
Olive Dieumerci
THThierry Habyarimana
Thierry Habyarimana
PNPacifique Ndishimye
Pacifique Ndishimye
MOMounia Oudghiri
Mounia Oudghiri
The WHO and CDC recently declared monkeypox virus (MPXV) a zoonotic disease known as monkeypox (Mpox) a Public Health Emergency of International Concern. According to the CDC, no treatment is specifically approved for Mpox infections. Medicinal plants are crucial in healthcare and economic development, particularly for low- and middle-income countries. This review offers valuable insights into the pathogenesis and the management of Mpox through therapeutic approaches and vaccination strategies using plant-based molecules. Core structural proteins necessary for both viral entry and the immune response, including A29, H3L, and L1R, are involved in the pathogenesis of MPXV. Potential targets for vaccines include proteins like A35R and B6R, which are essential to the propagation of viruses. The MPXV evades the immune system by concealing its DNA, suppressing the interferon response, limiting T and NK cell activation, and preventing apoptosis, complicating vaccine and treatment development. Antivirals (tecovirimat, brincidofovir) and vaccinations (JYNNEOS, ACAM2000) manage Mpox. A recent study revealed early clinical trial results, indicating that the antiviral drug tecovirimat, a well-known conventional treatment, is no more effective than a placebo against the clade I virus type Research gaps, low vaccination effectiveness, and availability are challenges. This review offers a novel perspective on combating the global threat of Mpox by investigating alternative management strategies centered on plant-derived compounds. Graphical Abstract

Verified
Journal Article
Open access
PDF file
TKTakeo Kondo
Takeo Kondo
SKSonoko Kondo
Sonoko Kondo
NHNakayama-Imaohji Haruyuki
Nakayama-Imaohji Haruyuki
ATAyano Tada
Ayano Tada
NTNAFISA TABASSUM
NAFISA TABASSUM
TKTomomi Kuwahara
Tomomi Kuwahara
Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn’s disease, are chronic disorders relating to gut microbiota dysbiosis. Despite severe pancolitis being more prevalent in pediatric UC than in adults, alterations in the colon mucosa-associated microbiota (MAM) and their association with disease severity remain to be elucidated. The present study aimed to compare the gut microbiota in colon lavage fluids (CLFs) and fecal samples from 19 pediatric UC and 19 non-IBD patients. The community structure of MAM inferred by 16S metagenomic analysis was similar throughout the colon regardless of disease type. Bacterial compositions between MAM and feces were significantly different in non-IBD, while no difference was observed in pediatric UC, indicating a compromised mucous layer that could not sufficiently separate the MAM and luminal microbiota in UC. In pediatric UC, homogenous distribution of MAM was gradually disordered with increases in disease activity or mucosal inflammation, and bacterial groups of upper digestive tract or environmental origin were more abundant in MAM. Monitoring key bacterial markers in MAM, which include Lactobacillus and Enterococcus or Faecalibacterium and Blautia as increased or reduced members in pediatric UC, respectively, might be useful for evaluation of patient prognosis.

1 January 2023 in Journal of Advanced Biotechnology and Experimental Therapeutics
Verified
Journal Article
Closed access
HMHiberte Migabo
Hiberte Migabo
EMEmmanuel Munyeshyaka
Emmanuel Munyeshyaka
CICedrick Izere
Cedrick Izere
CYCallixte Yadufashije
Callixte Yadufashije
FNFran Niyonzima
Fran Niyonzima
THThierry Habyarimana
Thierry Habyarimana
Infectious diseases remain a global health challenge as result of antimicrobial resistance. The use of natural products has revealed a potential source of alternative antimicrobial agents. The aim of this research was to evaluate the antibacterial activities and the phytoconstituents of Tragia brevipes against pathogenic bacteria. The crude extracts of leaves, roots and stems were obtained using polar and non-polar solvents and the antibacterial assay was performed using agar well diffusion and disc diffusion methods. The results showed that in the leaves and roots, flavonoids, saponins, glycosides, phenols, tannins and resins were present whereas in the stem, flavonoids, glycosides and resins were present. Only S. aureus ATCC43300, E. coli ATCC25922 did not show inhibition zone to all plant parts, P. aeruginosa ATTCC27853 showed the highest inhibition zone compared to other bacteria. It was observed that methanolic extract has a great potential antimicrobial activity, followed by distilled water extracts. The combination of plant extracts showed a marked synergic effect. The two way ANOVA showed a statistical difference in the mean zone of inhibition obtained among bacteria and leaves (f = 2.3478, p < 0.05), roots (f = 2.3478, p < 0.05) whereas stem extracts difference was between solvents and tested bacteria (f = 3.4923, p < 0.05). T. brevipes could be a potential candidate in bacterial infection treatment as a source of novel antimicrobial agents. Further studies are recommended to isolate the active ingredients and investigate pharmacological properties.